| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | WBP2 SMARCA2 SMARCA4 NCOA1 SMARCD1 TSG101 PRPF6 BCL9 SSBP3 EP300 | 2.15e-08 | 303 | 60 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | WBP2 PA2G4 TLE3 SMARCA2 SMARCA4 NCOA1 SMARCD1 TSG101 PRPF6 BCL9 SSBP3 EP300 | 8.98e-08 | 562 | 60 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ZNF729 YTHDF1 WBP2 COL11A1 PA2G4 TLE3 SMARCA2 SMARCA4 NCOA1 SMARCD1 TSG101 IRS1 PRPF6 BCL9 SSBP3 EP300 | 2.01e-07 | 1160 | 60 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.58e-07 | 46 | 60 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ZNF729 YTHDF1 WBP2 COL11A1 PA2G4 TLE3 SMARCA2 SMARCA4 NCOA1 SMARCD1 TSG101 IRS1 PRPF6 BCL9 SSBP3 EP300 | 1.61e-06 | 1356 | 60 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin binding | WBP2 PBRM1 PYGO2 PELP1 SMARCA2 SMARCA4 AUTS2 NCOA1 SMARCD1 NONO EP300 | 1.08e-05 | 739 | 60 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.32e-04 | 33 | 60 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.86e-04 | 37 | 60 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.46e-04 | 187 | 60 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.52e-04 | 188 | 60 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 4.80e-04 | 11 | 60 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 6.78e-04 | 13 | 60 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | SUMO binding | 1.47e-03 | 19 | 60 | 2 | GO:0032183 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.55e-03 | 417 | 60 | 6 | GO:0061629 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.45e-06 | 29 | 60 | 4 | GO:2000819 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF729 WBP2 PELP1 TBX21 SMARCA2 SMARCA4 AUTS2 ETV5 NCOA1 SSBP2 PRPF6 SSBP4 BCL9 SSBP3 EP300 TBP | 1.46e-06 | 1390 | 60 | 16 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 6.67e-06 | 42 | 60 | 4 | GO:0070316 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 7.54e-06 | 162 | 60 | 6 | GO:0045621 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 8.05e-06 | 44 | 60 | 4 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 8.33e-06 | 95 | 60 | 5 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.18e-05 | 266 | 60 | 7 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.84e-05 | 54 | 60 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 3.84e-05 | 65 | 60 | 4 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 4.58e-05 | 68 | 60 | 4 | GO:0141137 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 4.73e-05 | 136 | 60 | 5 | GO:0045445 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 4.95e-05 | 226 | 60 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 6.00e-05 | 143 | 60 | 5 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 6.20e-05 | 144 | 60 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 6.62e-05 | 146 | 60 | 5 | GO:2000779 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 7.23e-05 | 242 | 60 | 6 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 7.23e-05 | 242 | 60 | 6 | GO:1903708 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.08e-04 | 377 | 60 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.10e-04 | 378 | 60 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.12e-04 | 379 | 60 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.23e-04 | 385 | 60 | 7 | GO:0051251 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 1.24e-04 | 6 | 60 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 1.26e-04 | 88 | 60 | 4 | GO:0006289 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 1.49e-04 | 92 | 60 | 4 | GO:0045661 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.69e-04 | 95 | 60 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | tendon development | 1.73e-04 | 7 | 60 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.91e-04 | 98 | 60 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 2.06e-04 | 100 | 60 | 4 | GO:0007091 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 2.07e-04 | 186 | 60 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 2.20e-04 | 423 | 60 | 7 | GO:0002696 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 2.31e-04 | 103 | 60 | 4 | GO:0044784 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 2.39e-04 | 429 | 60 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 3.07e-04 | 111 | 60 | 4 | GO:0033045 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 3.16e-04 | 449 | 60 | 7 | GO:0050867 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 3.85e-04 | 614 | 60 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 4.07e-04 | 333 | 60 | 6 | GO:0051054 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 4.41e-04 | 51 | 60 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | RNA polymerase I preinitiation complex assembly | 4.50e-04 | 11 | 60 | 2 | GO:0001188 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 4.50e-04 | 11 | 60 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | DNA repair | 5.50e-04 | 648 | 60 | 8 | GO:0006281 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 5.51e-04 | 55 | 60 | 3 | GO:0035886 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 5.58e-04 | 231 | 60 | 5 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 5.92e-04 | 234 | 60 | 5 | GO:0006282 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF729 MAGEL2 PA2G4 TLE3 TBX21 SMARCA2 SMARCA4 ETV5 TSG101 NONO EP300 SCAF4 | 6.03e-04 | 1399 | 60 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | rhythmic process | 6.14e-04 | 360 | 60 | 6 | GO:0048511 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF729 MAGEL2 PA2G4 TLE3 TBX21 SMARCA2 SMARCA4 ETV5 TSG101 NONO EP300 SCAF4 | 6.59e-04 | 1413 | 60 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 7.19e-04 | 139 | 60 | 4 | GO:0051983 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 8.36e-04 | 382 | 60 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 8.59e-04 | 64 | 60 | 3 | GO:0010171 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 9.13e-04 | 537 | 60 | 7 | GO:0030098 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 9.43e-04 | 540 | 60 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 1.10e-03 | 17 | 60 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | regulation of cell development | ROCK2 PBRM1 INPP5D TBX21 SMARCA2 SMARCA4 ETV5 SMARCD1 GSX2 EP300 | 1.14e-03 | 1095 | 60 | 10 | GO:0060284 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.16e-03 | 727 | 60 | 8 | GO:0032870 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase I promoter | 1.24e-03 | 18 | 60 | 2 | GO:0006361 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.26e-03 | 917 | 60 | 9 | GO:0016071 | |
| GeneOntologyBiologicalProcess | mammary gland development | 1.27e-03 | 162 | 60 | 4 | GO:0030879 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.31e-03 | 741 | 60 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.41e-03 | 76 | 60 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.52e-03 | 78 | 60 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 1.54e-03 | 290 | 60 | 5 | GO:0050870 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | PBRM1 PA2G4 INPP5D SMARCA2 SMARCA4 ETV5 NCOA1 SMARCD1 GSX2 EP300 | 1.55e-03 | 1141 | 60 | 10 | GO:0045597 |
| GeneOntologyCellularComponent | collagen trimer | 2.16e-07 | 88 | 61 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.70e-06 | 30 | 61 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.10e-06 | 12 | 61 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.10e-06 | 12 | 61 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 6.62e-06 | 13 | 61 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PBRM1 PYGO2 PELP1 TLE3 NPAP1 RBM42 SMARCA2 SMARCA4 NCOA1 SMARCD1 PRPF6 BCL9 SNRPC NONO TBP | 7.00e-06 | 1377 | 61 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | npBAF complex | 8.41e-06 | 14 | 61 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 8.41e-06 | 14 | 61 | 3 | GO:0140288 | |
| GeneOntologyCellularComponent | RSC-type complex | 1.05e-05 | 15 | 61 | 3 | GO:0016586 | |
| GeneOntologyCellularComponent | nBAF complex | 1.29e-05 | 16 | 61 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.03e-05 | 21 | 61 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 5.01e-05 | 4 | 61 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | collagen type V trimer | 5.01e-05 | 4 | 61 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 8.33e-05 | 5 | 61 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 1.25e-04 | 6 | 61 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.40e-04 | 272 | 61 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.78e-04 | 96 | 61 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | chromatin | WBP2 PBRM1 PELP1 TBX21 SMARCA2 SMARCA4 ETV5 NCOA1 NKX1-1 SMARCD1 GSX2 EP300 TBP | 2.84e-04 | 1480 | 61 | 13 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | 3.24e-04 | 596 | 61 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | bBAF complex | 3.71e-04 | 10 | 61 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | ATPase complex | 5.50e-04 | 129 | 61 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | brahma complex | 7.45e-04 | 14 | 61 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nuclear matrix | 7.48e-04 | 140 | 61 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | euchromatin | 1.22e-03 | 72 | 61 | 3 | GO:0000791 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.57e-03 | 171 | 61 | 4 | GO:0034399 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 2.79e-03 | 96 | 61 | 3 | GO:0097525 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.82e-03 | 332 | 61 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 3.78e-03 | 107 | 61 | 3 | GO:0030532 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 5.09e-03 | 119 | 61 | 3 | GO:0120114 | |
| HumanPheno | Narrow nasal bridge | 4.96e-09 | 53 | 26 | 7 | HP:0000446 | |
| HumanPheno | Short palm | 1.37e-06 | 118 | 26 | 7 | HP:0004279 | |
| HumanPheno | Narrow palm | 2.45e-06 | 20 | 26 | 4 | HP:0004283 | |
| HumanPheno | Thick eyebrow | 8.17e-06 | 154 | 26 | 7 | HP:0000574 | |
| HumanPheno | Sporadic | 9.79e-06 | 103 | 26 | 6 | HP:0003745 | |
| HumanPheno | Class III obesity | 1.90e-05 | 11 | 26 | 3 | HP:0025501 | |
| HumanPheno | Aggressive behavior | MAGEL2 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 1.94e-05 | 516 | 26 | 11 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | MAGEL2 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 1.94e-05 | 516 | 26 | 11 | HP:0006919 |
| HumanPheno | Frontal upsweep of hair | 1.97e-05 | 33 | 26 | 4 | HP:0002236 | |
| HumanPheno | Small hand | 2.59e-05 | 122 | 26 | 6 | HP:0200055 | |
| HumanPheno | Thin upper lip vermilion | COL11A1 MAGEL2 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 NONO EP300 | 2.61e-05 | 339 | 26 | 9 | HP:0000219 |
| HumanPheno | Thin lips | COL11A1 MAGEL2 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 NONO EP300 | 2.61e-05 | 339 | 26 | 9 | HP:0000213 |
| HumanPheno | Thin vermilion border | COL11A1 MAGEL2 NPAP1 SMARCA2 SMARCA4 SMARCD1 KCNE5 HERC2 NONO EP300 | 2.71e-05 | 433 | 26 | 10 | HP:0000233 |
| HumanPheno | Myopia | COL5A1 COL9A2 COL11A1 MAGEL2 NPAP1 SMARCA4 SMARCD1 KCNE5 HERC2 NONO | 3.59e-05 | 447 | 26 | 10 | HP:0000545 |
| HumanPheno | Low 5-minute APGAR score | 4.14e-05 | 14 | 26 | 3 | HP:0030919 | |
| HumanPheno | Disinhibition | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 4.99e-05 | 807 | 26 | 13 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 4.99e-05 | 807 | 26 | 13 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 4.99e-05 | 807 | 26 | 13 | HP:5200123 |
| HumanPheno | Social disinhibition | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 4.99e-05 | 807 | 26 | 13 | HP:5200029 |
| HumanPheno | Acromicria | 5.16e-05 | 15 | 26 | 3 | HP:0031878 | |
| HumanPheno | Low 1-minute APGAR score | 5.16e-05 | 15 | 26 | 3 | HP:0030918 | |
| HumanPheno | Abnormal hair whorl | 5.23e-05 | 42 | 26 | 4 | HP:0010721 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 7.72e-05 | 298 | 26 | 8 | HP:0006494 | |
| HumanPheno | Delayed ability to walk | 8.89e-05 | 304 | 26 | 8 | HP:0031936 | |
| HumanPheno | Abnormally increased volition | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 1.11e-04 | 869 | 26 | 13 | HP:5200263 |
| HumanPheno | Low APGAR score | 1.27e-04 | 20 | 26 | 3 | HP:0030917 | |
| HumanPheno | Genu valgum | 1.42e-04 | 165 | 26 | 6 | HP:0002857 | |
| HumanPheno | Abnormality of the dentition | COL5A1 COL9A2 COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 SMARCD1 KCNE5 HERC2 NONO EP300 RUSC2 | 1.46e-04 | 1030 | 26 | 14 | HP:0000164 |
| HumanPheno | Poor gross motor coordination | 1.48e-04 | 21 | 26 | 3 | HP:0007015 | |
| HumanPheno | Widened distal phalanges | 1.49e-04 | 4 | 26 | 2 | HP:0006200 | |
| HumanPheno | Flat face | 1.65e-04 | 106 | 26 | 5 | HP:0012368 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | COL9A2 COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 EP300 | 1.76e-04 | 538 | 26 | 10 | HP:0005927 |
| HumanPheno | Abnormal social development | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 1.77e-04 | 908 | 26 | 13 | HP:0025732 |
| HumanPheno | Joint hypermobility | COL5A1 COL9A2 COL11A1 SMARCA2 SMARCA4 SMARCD1 NONO EP300 SCAF4 RUSC2 | 2.35e-04 | 557 | 26 | 10 | HP:0001382 |
| HumanPheno | Hyperactivity | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 EP300 RUSC2 | 2.39e-04 | 558 | 26 | 10 | HP:0000752 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 2.67e-04 | 456 | 26 | 9 | HP:0009485 | |
| HumanPheno | Labial hypoplasia | 2.75e-04 | 64 | 26 | 4 | HP:0000066 | |
| HumanPheno | Decreased muscle mass | 2.75e-04 | 64 | 26 | 4 | HP:0003199 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | COL9A2 COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 EP300 | 2.93e-04 | 572 | 26 | 10 | HP:0006496 |
| HumanPheno | Chronic constipation | 2.95e-04 | 120 | 26 | 5 | HP:0012450 | |
| HumanPheno | Abnormal eyelid morphology | COL5A1 COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 KCNE5 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 2.98e-04 | 1408 | 26 | 16 | HP:0000492 |
| HumanPheno | Clinodactyly | COL11A1 MAGEL2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 | 3.02e-04 | 574 | 26 | 10 | HP:0030084 |
| HumanPheno | Abnormality of upper lip vermillion | COL11A1 MAGEL2 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 NONO EP300 | 3.04e-04 | 464 | 26 | 9 | HP:0011339 |
| HumanPheno | Abnormal knee morphology | 3.13e-04 | 364 | 26 | 8 | HP:0034669 | |
| HumanPheno | Hypoplastic female external genitalia | 3.48e-04 | 68 | 26 | 4 | HP:0012815 | |
| HumanPheno | Wide nasal base | 3.55e-04 | 28 | 26 | 3 | HP:0012810 | |
| HumanPheno | Thick vermilion border | 3.66e-04 | 279 | 26 | 7 | HP:0012471 | |
| HumanPheno | Abnormality of refraction | COL5A1 COL9A2 COL11A1 MAGEL2 NPAP1 SMARCA4 SMARCD1 KCNE5 HERC2 NONO EP300 | 3.70e-04 | 709 | 26 | 11 | HP:0000539 |
| HumanPheno | Prominent interphalangeal joints | 3.71e-04 | 6 | 26 | 2 | HP:0006237 | |
| HumanPheno | Abnormal eating behavior | 3.99e-04 | 128 | 26 | 5 | HP:0100738 | |
| HumanPheno | Delayed gross motor development | 3.99e-04 | 481 | 26 | 9 | HP:0002194 | |
| HumanPheno | Narrow palate | 4.27e-04 | 202 | 26 | 6 | HP:0000189 | |
| HumanPheno | Abnormal nasal base norphology | 4.37e-04 | 30 | 26 | 3 | HP:0012808 | |
| HumanPheno | Abnormality of the knee | 4.66e-04 | 491 | 26 | 9 | HP:0002815 | |
| HumanPheno | Deviated nasal septum | 5.18e-04 | 7 | 26 | 2 | HP:0004411 | |
| HumanPheno | Abdominal obesity | 6.36e-04 | 34 | 26 | 3 | HP:0012743 | |
| HumanPheno | Clitoral hypoplasia | 6.36e-04 | 34 | 26 | 3 | HP:0000060 | |
| HumanPheno | Aplasia/Hypoplasia of the clitoris | 6.36e-04 | 34 | 26 | 3 | HP:0040255 | |
| HumanPheno | Reduced impulse control | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 6.64e-04 | 1032 | 26 | 13 | HP:5200045 |
| HumanPheno | Hypoplastic labia minora | 6.93e-04 | 35 | 26 | 3 | HP:0000064 | |
| HumanPheno | Abnormal palm morphology | 7.24e-04 | 521 | 26 | 9 | HP:0100871 | |
| HumanPheno | Abnormal hip bone morphology | COL5A1 COL9A2 PHLDB1 COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 HERC2 EP300 | 8.62e-04 | 653 | 26 | 10 | HP:0003272 |
| HumanPheno | Abnormality of mouth size | 8.93e-04 | 425 | 26 | 8 | HP:0011337 | |
| HumanPheno | Short foot | 9.04e-04 | 153 | 26 | 5 | HP:0001773 | |
| HumanPheno | Short feet | 9.04e-04 | 153 | 26 | 5 | HP:0001766 | |
| HumanPheno | Small feet | 9.04e-04 | 153 | 26 | 5 | HP:0001764 | |
| HumanPheno | Deviation of the hallux | 9.30e-04 | 88 | 26 | 4 | HP:0010051 | |
| HumanPheno | Abnormal labia morphology | 9.30e-04 | 88 | 26 | 4 | HP:0000058 | |
| HumanPheno | Abnormal curvature of the vertebral column | COL5A1 COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 RUSC2 | 9.36e-04 | 1219 | 26 | 14 | HP:0010674 |
| HumanPheno | Thick nasal alae | 9.55e-04 | 39 | 26 | 3 | HP:0009928 | |
| HumanPheno | Congenital abnormal hair pattern | 9.56e-04 | 327 | 26 | 7 | HP:0011361 | |
| HumanPheno | Hypoplastic facial bones | 1.03e-03 | 331 | 26 | 7 | HP:0002692 | |
| HumanPheno | Abnormality of the joints of the lower limbs | 1.03e-03 | 547 | 26 | 9 | HP:0100239 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 1.05e-03 | 332 | 26 | 7 | HP:0034261 | |
| HumanPheno | Malar flattening | 1.07e-03 | 240 | 26 | 6 | HP:0000272 | |
| HumanPheno | Abnormal labia minora morphology | 1.11e-03 | 41 | 26 | 3 | HP:0012880 | |
| HumanPheno | Autistic behavior | MAGEL2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 | 1.16e-03 | 678 | 26 | 10 | HP:0000729 |
| HumanPheno | Hip dysplasia | 1.24e-03 | 247 | 26 | 6 | HP:0001385 | |
| HumanPheno | Radial deviation of finger | 1.27e-03 | 448 | 26 | 8 | HP:0009466 | |
| HumanPheno | Temperature instability | 1.27e-03 | 43 | 26 | 3 | HP:0005968 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 1.29e-03 | 564 | 26 | 9 | HP:0009484 | |
| HumanPheno | Abnormal malar bone morphology | 1.29e-03 | 249 | 26 | 6 | HP:0012369 | |
| HumanPheno | Talipes equinovalgus | 1.31e-03 | 166 | 26 | 5 | HP:0001772 | |
| HumanPheno | Abnormal zygomatic arch morphology | 1.32e-03 | 250 | 26 | 6 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 1.32e-03 | 250 | 26 | 6 | HP:0010668 | |
| HumanPheno | Sleep apnea | 1.38e-03 | 168 | 26 | 5 | HP:0010535 | |
| HumanPheno | Abnormality of the upper respiratory tract | COL5A1 COL11A1 MAGEL2 TBX21 NPAP1 SMARCA2 SMARCA4 SMARCD1 HERC2 NONO EP300 SCAF4 TBP | 1.39e-03 | 1111 | 26 | 13 | HP:0002087 |
| HumanPheno | Sleep-related breathing disorders | 1.41e-03 | 169 | 26 | 5 | HP:5200283 | |
| HumanPheno | Bowing of the legs | 1.43e-03 | 254 | 26 | 6 | HP:0002979 | |
| HumanPheno | Broad philtrum | 1.45e-03 | 45 | 26 | 3 | HP:0000289 | |
| HumanPheno | Scoliosis | COL5A1 MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 RUSC2 | 1.53e-03 | 1122 | 26 | 13 | HP:0002650 |
| HumanPheno | Delayed speech and language development | MAGEL2 NPAP1 SMARCA2 SMARCA4 AUTS2 FMN2 SMARCD1 GSX2 HERC2 NONO EP300 SCAF4 RUSC2 | 1.54e-03 | 1123 | 26 | 13 | HP:0000750 |
| HumanPheno | Hypoplasia of the phalanges of the toes | 1.60e-03 | 12 | 26 | 2 | HP:0010746 | |
| HumanPheno | Abnormal upper lip morphology | COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 | 1.61e-03 | 980 | 26 | 12 | HP:0000177 |
| HumanPheno | Talipes | 1.64e-03 | 583 | 26 | 9 | HP:0001883 | |
| HumanPheno | Abnormality of calvarial morphology | COL5A1 COL9A2 COL11A1 MAGEL2 CCBE1 NPAP1 SMARCA2 AUTS2 SMARCD1 HERC2 NONO EP300 RUSC2 | 1.69e-03 | 1134 | 26 | 13 | HP:0002648 |
| HumanPheno | Positional foot deformity | 1.72e-03 | 587 | 26 | 9 | HP:0005656 | |
| HumanPheno | Oligomenorrhea | 1.75e-03 | 48 | 26 | 3 | HP:0000876 | |
| HumanPheno | Impairment in personality functioning | MAGEL2 CCBE1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCD1 HERC2 NONO EP300 SCAF4 TBP RUSC2 | 1.80e-03 | 1141 | 26 | 13 | HP:0031466 |
| HumanPheno | Broad foot | 1.83e-03 | 179 | 26 | 5 | HP:0001769 | |
| Domain | SSDP_DNA-bd | 2.84e-08 | 3 | 58 | 3 | IPR008116 | |
| Domain | Collagen | 2.49e-07 | 85 | 58 | 6 | IPR008160 | |
| Domain | Collagen | 2.49e-07 | 85 | 58 | 6 | PF01391 | |
| Domain | Bromodomain_CS | 1.19e-06 | 26 | 58 | 4 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 5.12e-06 | 37 | 58 | 4 | PS00633 | |
| Domain | Bromodomain | 5.71e-06 | 38 | 58 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 7.78e-06 | 41 | 58 | 4 | PS50014 | |
| Domain | BROMO | 8.58e-06 | 42 | 58 | 4 | SM00297 | |
| Domain | Bromodomain | 8.58e-06 | 42 | 58 | 4 | IPR001487 | |
| Domain | - | 8.58e-06 | 42 | 58 | 4 | 1.20.920.10 | |
| Domain | SnAC | 9.48e-06 | 2 | 58 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 9.48e-06 | 2 | 58 | 2 | IPR014978 | |
| Domain | SnAC | 9.48e-06 | 2 | 58 | 2 | IPR029295 | |
| Domain | SnAC | 9.48e-06 | 2 | 58 | 2 | PF14619 | |
| Domain | QLQ | 9.48e-06 | 2 | 58 | 2 | SM00951 | |
| Domain | QLQ | 9.48e-06 | 2 | 58 | 2 | PS51666 | |
| Domain | QLQ | 9.48e-06 | 2 | 58 | 2 | PF08880 | |
| Domain | TSPN | 4.82e-05 | 23 | 58 | 3 | SM00210 | |
| Domain | HSA | 5.66e-05 | 4 | 58 | 2 | SM00573 | |
| Domain | HSA | 5.66e-05 | 4 | 58 | 2 | PS51204 | |
| Domain | HSA_dom | 5.66e-05 | 4 | 58 | 2 | IPR014012 | |
| Domain | HSA | 5.66e-05 | 4 | 58 | 2 | PF07529 | |
| Domain | LisH | 8.81e-05 | 28 | 58 | 3 | SM00667 | |
| Domain | LisH | 8.81e-05 | 28 | 58 | 3 | IPR006594 | |
| Domain | LISH | 8.81e-05 | 28 | 58 | 3 | PS50896 | |
| Domain | SNF2_N | 1.32e-04 | 32 | 58 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.32e-04 | 32 | 58 | 3 | PF00176 | |
| Domain | BRK | 1.41e-04 | 6 | 58 | 2 | SM00592 | |
| Domain | Nuc_rcpt_coact | 1.41e-04 | 6 | 58 | 2 | IPR009110 | |
| Domain | BRK_domain | 1.41e-04 | 6 | 58 | 2 | IPR006576 | |
| Domain | SWIB_MDM2_domain | 1.41e-04 | 6 | 58 | 2 | IPR003121 | |
| Domain | BRK | 1.41e-04 | 6 | 58 | 2 | PF07533 | |
| Domain | - | 1.41e-04 | 6 | 58 | 2 | 1.10.245.10 | |
| Domain | Fib_collagen_C | 5.12e-04 | 11 | 58 | 2 | IPR000885 | |
| Domain | COLFI | 5.12e-04 | 11 | 58 | 2 | PF01410 | |
| Domain | NC1_FIB | 5.12e-04 | 11 | 58 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 5.12e-04 | 11 | 58 | 2 | PD002078 | |
| Domain | COLFI | 5.12e-04 | 11 | 58 | 2 | SM00038 | |
| Domain | Laminin_G | 7.77e-04 | 58 | 58 | 3 | IPR001791 | |
| Domain | ZZ | 1.40e-03 | 18 | 58 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.40e-03 | 18 | 58 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.40e-03 | 18 | 58 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.57e-03 | 19 | 58 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.57e-03 | 19 | 58 | 2 | SM00291 | |
| Domain | Kunitz_BPTI | 2.30e-03 | 23 | 58 | 2 | IPR002223 | |
| Domain | - | 3.21e-03 | 95 | 58 | 3 | 2.60.120.200 | |
| Domain | RRM_1 | 3.96e-03 | 208 | 58 | 4 | PF00076 | |
| Domain | Helicase_C | 4.49e-03 | 107 | 58 | 3 | PF00271 | |
| Domain | HELICc | 4.49e-03 | 107 | 58 | 3 | SM00490 | |
| Domain | Helicase_C | 4.61e-03 | 108 | 58 | 3 | IPR001650 | |
| Domain | RRM | 4.61e-03 | 217 | 58 | 4 | SM00360 | |
| Domain | HELICASE_CTER | 4.73e-03 | 109 | 58 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.73e-03 | 109 | 58 | 3 | PS51192 | |
| Domain | DEXDc | 4.73e-03 | 109 | 58 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.85e-03 | 110 | 58 | 3 | IPR014001 | |
| Domain | RRM_dom | 5.40e-03 | 227 | 58 | 4 | IPR000504 | |
| Domain | RRM | 5.65e-03 | 230 | 58 | 4 | PS50102 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.21e-09 | 37 | 43 | 6 | M27797 | |
| Pathway | PID_REG_GR_PATHWAY | 4.72e-09 | 82 | 43 | 7 | M115 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.30e-08 | 26 | 43 | 5 | MM14793 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.41e-08 | 34 | 43 | 5 | MM15531 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.43e-07 | 41 | 43 | 5 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.07e-07 | 44 | 43 | 5 | M27812 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.63e-07 | 24 | 43 | 4 | M13404 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.09e-06 | 61 | 43 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.74e-06 | 67 | 43 | 5 | M26999 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.86e-06 | 74 | 43 | 5 | M160 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.98e-06 | 301 | 43 | 8 | MM15983 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 3.13e-06 | 10 | 43 | 3 | MM1532 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.27e-06 | 76 | 43 | 5 | MM14573 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 5.71e-06 | 12 | 43 | 3 | M22006 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.54e-06 | 90 | 43 | 5 | M631 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 7.80e-06 | 158 | 43 | 6 | MM14791 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 7.96e-06 | 91 | 43 | 5 | M27101 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.12e-05 | 46 | 43 | 4 | M198 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.91e-05 | 22 | 43 | 3 | MM1370 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.92e-05 | 63 | 43 | 4 | MM15613 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.17e-05 | 64 | 43 | 4 | M26953 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 6.55e-05 | 26 | 43 | 3 | M2499 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 6.99e-05 | 233 | 43 | 6 | M27099 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 7.68e-05 | 237 | 43 | 6 | M27786 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 8.04e-05 | 239 | 43 | 6 | MM14756 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 9.09e-05 | 78 | 43 | 4 | M27234 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 9.14e-05 | 29 | 43 | 3 | M48076 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 9.74e-05 | 153 | 43 | 5 | MM15522 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.12e-04 | 254 | 43 | 6 | M27131 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.35e-04 | 6 | 43 | 2 | M22062 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.62e-04 | 35 | 43 | 3 | M47969 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.63e-04 | 272 | 43 | 6 | M29619 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.65e-04 | 91 | 43 | 4 | M39700 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 1.89e-04 | 7 | 43 | 2 | M6907 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 2.41e-04 | 40 | 43 | 3 | MM14936 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.52e-04 | 8 | 43 | 2 | M22058 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.79e-04 | 42 | 43 | 3 | M48237 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.79e-04 | 42 | 43 | 3 | M27272 | |
| Pathway | WP_MRNA_PROCESSING | 3.89e-04 | 451 | 43 | 7 | MM15946 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.62e-04 | 330 | 43 | 6 | M7847 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.69e-04 | 50 | 43 | 3 | MM14796 | |
| Pathway | PID_AR_TF_PATHWAY | 5.57e-04 | 53 | 43 | 3 | M151 | |
| Pathway | WP_IL4_SIGNALING | 5.88e-04 | 54 | 43 | 3 | M39720 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 6.94e-04 | 13 | 43 | 2 | MM15622 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 7.03e-04 | 133 | 43 | 4 | MM15529 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 8.41e-04 | 61 | 43 | 3 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.52e-04 | 140 | 43 | 4 | M587 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 8.98e-04 | 142 | 43 | 4 | M48257 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M119 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27 | 9.31e-04 | 15 | 43 | 2 | M47973 | |
| Pathway | PID_RB_1PATHWAY | 1.01e-03 | 65 | 43 | 3 | M279 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.07e-03 | 149 | 43 | 4 | M27888 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.08e-03 | 258 | 43 | 5 | MM14572 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.35e-03 | 18 | 43 | 2 | M26942 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.50e-03 | 19 | 43 | 2 | MM15512 | |
| Pathway | WP_LEPTIN_SIGNALING | 1.59e-03 | 76 | 43 | 3 | M39491 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.59e-03 | 76 | 43 | 3 | MM14867 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.67e-03 | 20 | 43 | 2 | MM15061 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.84e-03 | 21 | 43 | 2 | M39593 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.84e-03 | 80 | 43 | 3 | M223 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.94e-03 | 175 | 43 | 4 | MM14941 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.10e-03 | 300 | 43 | 5 | M610 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.19e-03 | 85 | 43 | 3 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 2.67e-03 | 191 | 43 | 4 | MM15586 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.01e-03 | 95 | 43 | 3 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 3.19e-03 | 97 | 43 | 3 | M48262 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 3.21e-03 | 201 | 43 | 4 | M39605 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 3.48e-03 | 100 | 43 | 3 | MM15826 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 3.50e-03 | 29 | 43 | 2 | M39890 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 3.74e-03 | 30 | 43 | 2 | M207 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.74e-03 | 30 | 43 | 2 | M27772 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 3.74e-03 | 30 | 43 | 2 | M42517 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 3.74e-03 | 30 | 43 | 2 | MM15173 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.74e-03 | 30 | 43 | 2 | MM15517 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 4.00e-03 | 31 | 43 | 2 | M39522 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.25e-03 | 32 | 43 | 2 | MM14924 | |
| Pathway | PID_IL12_STAT4_PATHWAY | 4.25e-03 | 32 | 43 | 2 | M290 | |
| Pathway | WP_PRION_DISEASE_PATHWAY | 4.25e-03 | 32 | 43 | 2 | M39636 | |
| Pathway | WP_THERMOGENESIS | 4.32e-03 | 108 | 43 | 3 | M39746 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 4.42e-03 | 220 | 43 | 4 | M27794 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 4.43e-03 | 109 | 43 | 3 | M39542 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 4.55e-03 | 110 | 43 | 3 | MM15977 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.22e-03 | 532 | 43 | 6 | M27870 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 5.36e-03 | 36 | 43 | 2 | M542 | |
| Pubmed | YTHDF1 PBRM1 PYGO2 TLE3 SMARCA2 SMARCA4 AUTS2 ETV5 NCOA1 SMARCD1 SSBP2 HERC2 SSBP4 BCL9 SSBP3 PRRC2A EP300 SCAF4 TBP | 2.33e-12 | 1429 | 61 | 19 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | PBRM1 PYGO2 TLE3 SMARCA2 SMARCA4 AUTS2 NCOA1 SMARCD1 SSBP2 BCL9 EP300 | 2.52e-11 | 351 | 61 | 11 | 38297188 |
| Pubmed | ZNF680 PA2G4 TLE3 INPP5D SMARCA2 SMARCA4 ETV5 NCOA1 SMARCD1 PRPF6 FAM98B BCL9 NONO PRRC2A EP300 SCAF4 | 5.00e-11 | 1103 | 61 | 16 | 34189442 | |
| Pubmed | 2.68e-10 | 152 | 61 | 8 | 38360978 | ||
| Pubmed | 5.96e-10 | 8 | 61 | 4 | 18042045 | ||
| Pubmed | 1.02e-09 | 268 | 61 | 9 | 33640491 | ||
| Pubmed | 1.61e-09 | 29 | 61 | 5 | 19279220 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.98e-09 | 220 | 61 | 8 | 35785414 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 12079286 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | YTHDF1 WBP2 EIF2D AUTS2 NCOA1 TSG101 HERC2 SSBP3 SNRPC NONO PRRC2A SCAF4 ENOX2 | 5.95e-09 | 922 | 61 | 13 | 27609421 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.90e-09 | 457 | 61 | 10 | 32344865 | |
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 8.46e-09 | 14 | 61 | 4 | 36289231 | |
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 8.46e-09 | 14 | 61 | 4 | 8895581 | |
| Pubmed | 1.15e-08 | 15 | 61 | 4 | 23785148 | ||
| Pubmed | 1.15e-08 | 15 | 61 | 4 | 17640523 | ||
| Pubmed | 2.00e-08 | 17 | 61 | 4 | 11078522 | ||
| Pubmed | 2.00e-08 | 17 | 61 | 4 | 19183483 | ||
| Pubmed | Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. | 2.05e-08 | 4 | 61 | 3 | 24421395 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 3.25e-08 | 19 | 61 | 4 | 12110891 | |
| Pubmed | 3.42e-08 | 183 | 61 | 7 | 36129980 | ||
| Pubmed | 4.06e-08 | 20 | 61 | 4 | 9128241 | ||
| Pubmed | 4.57e-08 | 55 | 61 | 5 | 35945219 | ||
| Pubmed | Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway. | 5.01e-08 | 21 | 61 | 4 | 20460684 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 18487222 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 7.39e-08 | 23 | 61 | 4 | 30962207 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 7.39e-08 | 23 | 61 | 4 | 8804307 | |
| Pubmed | 8.86e-08 | 24 | 61 | 4 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 8.86e-08 | 24 | 61 | 4 | 10078207 | |
| Pubmed | 8.86e-08 | 24 | 61 | 4 | 12215535 | ||
| Pubmed | Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex. | 1.02e-07 | 6 | 61 | 3 | 15774904 | |
| Pubmed | WBP2 PA2G4 SMARCA2 SMARCA4 SMARCD1 TSG101 PRPF6 SNRPC NONO PRRC2A | 1.11e-07 | 615 | 61 | 10 | 31048545 | |
| Pubmed | 1.24e-07 | 26 | 61 | 4 | 10778858 | ||
| Pubmed | 1.46e-07 | 27 | 61 | 4 | 29374058 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 1.70e-07 | 28 | 61 | 4 | 12192000 | |
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 1.79e-07 | 7 | 61 | 3 | 21079652 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.79e-07 | 7 | 61 | 3 | 9590696 | |
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 19371634 | ||
| Pubmed | USP34 COL5A1 PBRM1 PELP1 RNPEP SMARCA2 SMARCA4 PRPF6 HERC2 PRRC2A | 1.94e-07 | 653 | 61 | 10 | 22586326 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | YTHDF1 ROCK2 PBRM1 PA2G4 SMARCA2 SMARCA4 PRPF6 FAM98B SNRPC NONO SCAF4 | 2.31e-07 | 847 | 61 | 11 | 35235311 |
| Pubmed | 2.69e-07 | 78 | 61 | 5 | 28611094 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 26986003 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 2.86e-07 | 8 | 61 | 3 | 28296634 | |
| Pubmed | 3.48e-07 | 157 | 61 | 6 | 30186101 | ||
| Pubmed | 3.67e-07 | 83 | 61 | 5 | 28794006 | ||
| Pubmed | 4.30e-07 | 35 | 61 | 4 | 32504627 | ||
| Pubmed | 5.42e-07 | 37 | 61 | 4 | 24335282 | ||
| Pubmed | YTHDF1 COL11A1 PBRM1 PA2G4 RBM42 SMARCA4 SMARCD1 PRPF6 FAM98B HERC2 NONO PRRC2A SCAF4 | 5.90e-07 | 1371 | 61 | 13 | 36244648 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 6.06e-07 | 411 | 61 | 8 | 35182466 | |
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 20301505 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 6.11e-07 | 10 | 61 | 3 | 23129809 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 7.46e-07 | 40 | 61 | 4 | 34585037 | |
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 10454579 | ||
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 12917342 | ||
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 26965372 | ||
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 8.39e-07 | 11 | 61 | 3 | 25731772 | |
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 22334708 | ||
| Pubmed | USP34 COL5A1 PELP1 PA2G4 SSBP2 PRPF6 FAM98B SSBP4 SSBP3 NONO PRRC2A AHNAK2 TBP | 1.02e-06 | 1440 | 61 | 13 | 30833792 | |
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 35132438 | ||
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 11734557 | ||
| Pubmed | 1.45e-06 | 13 | 61 | 3 | 17340523 | ||
| Pubmed | 1.65e-06 | 638 | 61 | 9 | 31182584 | ||
| Pubmed | 1.84e-06 | 14 | 61 | 3 | 30510198 | ||
| Pubmed | 2.30e-06 | 15 | 61 | 3 | 14701856 | ||
| Pubmed | 2.30e-06 | 15 | 61 | 3 | 11263494 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 2.30e-06 | 15 | 61 | 3 | 11175787 | |
| Pubmed | 2.30e-06 | 15 | 61 | 3 | 19762545 | ||
| Pubmed | 2.30e-06 | 15 | 61 | 3 | 15985610 | ||
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 2.30e-06 | 15 | 61 | 3 | 17920018 | |
| Pubmed | 2.49e-06 | 220 | 61 | 6 | 24550385 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.78e-06 | 877 | 61 | 10 | 20211142 | |
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 2.83e-06 | 16 | 61 | 3 | 9710619 | |
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 2.83e-06 | 16 | 61 | 3 | 35390516 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 8670841 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 3.03e-06 | 2 | 61 | 2 | 23076393 | |
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 3.03e-06 | 2 | 61 | 2 | 9603422 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15576411 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23276717 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27097303 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15240517 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 3.03e-06 | 2 | 61 | 2 | 33027072 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28038711 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23872584 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 3.03e-06 | 2 | 61 | 2 | 23963727 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 3.03e-06 | 2 | 61 | 2 | 31375262 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 3.03e-06 | 2 | 61 | 2 | 23088494 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17075831 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20333683 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 34812766 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 3.03e-06 | 2 | 61 | 2 | 32855269 | |
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 3.03e-06 | 2 | 61 | 2 | 30478150 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10440698 | ||
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 3.03e-06 | 2 | 61 | 2 | 22721696 | |
| Pubmed | Noise-induced cochlear F-actin depolymerization is mediated via ROCK2/p-ERM signaling. | 3.03e-06 | 2 | 61 | 2 | 25683353 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18508913 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11719516 | ||
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 3.03e-06 | 2 | 61 | 2 | 25808524 | |
| Pubmed | Structure of a full-length cDNA clone for the pro-alpha1(V/XI) collagen chain of red seabream. | 3.03e-06 | 2 | 61 | 2 | 11342118 | |
| Interaction | PAX8 interactions | 3.92e-11 | 111 | 60 | 9 | int:PAX8 | |
| Interaction | TLX1 interactions | PBRM1 PYGO2 TLE3 SMARCA2 AUTS2 SMARCD1 SSBP2 BCL9 SSBP3 EP300 | 9.76e-11 | 175 | 60 | 10 | int:TLX1 |
| Interaction | LHX8 interactions | 2.00e-10 | 53 | 60 | 7 | int:LHX8 | |
| Interaction | CIITA interactions | 2.62e-10 | 55 | 60 | 7 | int:CIITA | |
| Interaction | AR interactions | USP34 PBRM1 PYGO2 PELP1 PA2G4 TLE3 SMARCA2 SMARCA4 ETV5 NCOA1 SMARCD1 TSG101 SSBP2 PRPF6 BCL9 NONO EP300 TBP | 3.22e-10 | 992 | 60 | 18 | int:AR |
| Interaction | LHX1 interactions | 7.26e-10 | 103 | 60 | 8 | int:LHX1 | |
| Interaction | SP7 interactions | PBRM1 PYGO2 TLE3 SMARCA2 SMARCA4 NCOA1 SMARCD1 BCL9 SSBP3 EP300 SCAF4 | 1.37e-09 | 304 | 60 | 11 | int:SP7 |
| Interaction | LHX4 interactions | 1.45e-09 | 166 | 60 | 9 | int:LHX4 | |
| Interaction | TBXT interactions | 1.88e-09 | 116 | 60 | 8 | int:TBXT | |
| Interaction | TEAD1 interactions | 2.43e-09 | 176 | 60 | 9 | int:TEAD1 | |
| Interaction | ETS1 interactions | 2.63e-09 | 121 | 60 | 8 | int:ETS1 | |
| Interaction | PAX7 interactions | 3.20e-09 | 124 | 60 | 8 | int:PAX7 | |
| Interaction | PAX9 interactions | 4.66e-09 | 130 | 60 | 8 | int:PAX9 | |
| Interaction | BCL9L interactions | 6.00e-09 | 48 | 60 | 6 | int:BCL9L | |
| Interaction | GATA2 interactions | 7.13e-09 | 199 | 60 | 9 | int:GATA2 | |
| Interaction | SOX9 interactions | 1.51e-08 | 97 | 60 | 7 | int:SOX9 | |
| Interaction | SS18L1 interactions | 1.62e-08 | 98 | 60 | 7 | int:SS18L1 | |
| Interaction | ERG interactions | 1.92e-08 | 223 | 60 | 9 | int:ERG | |
| Interaction | LHX6 interactions | 1.93e-08 | 58 | 60 | 6 | int:LHX6 | |
| Interaction | SSBP4 interactions | 2.15e-08 | 59 | 60 | 6 | int:SSBP4 | |
| Interaction | TBR1 interactions | 4.37e-08 | 113 | 60 | 7 | int:TBR1 | |
| Interaction | GCM1 interactions | 5.11e-08 | 68 | 60 | 6 | int:GCM1 | |
| Interaction | LHX2 interactions | 6.78e-08 | 183 | 60 | 8 | int:LHX2 | |
| Interaction | EP300 interactions | ROCK2 PELP1 PA2G4 TLE3 TBX21 SMARCA2 SMARCA4 AUTS2 ETV5 NCOA1 TSG101 SSBP2 PRPF6 SSBP4 NONO EP300 SCAF4 TBP | 7.19e-08 | 1401 | 60 | 18 | int:EP300 |
| Interaction | LHX3 interactions | 7.38e-08 | 185 | 60 | 8 | int:LHX3 | |
| Interaction | GATA3 interactions | 8.01e-08 | 187 | 60 | 8 | int:GATA3 | |
| Interaction | TNIP2 interactions | YTHDF1 WBP2 EIF2D AUTS2 NCOA1 SMARCD1 TSG101 HERC2 SSBP3 SNRPC NONO PRRC2A EP300 SCAF4 ENOX2 | 8.43e-08 | 952 | 60 | 15 | int:TNIP2 |
| Interaction | MYOD1 interactions | 1.06e-07 | 194 | 60 | 8 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.11e-07 | 195 | 60 | 8 | int:KLF5 | |
| Interaction | TLE3 interactions | 1.49e-07 | 376 | 60 | 10 | int:TLE3 | |
| Interaction | SOX7 interactions | 1.58e-07 | 82 | 60 | 6 | int:SOX7 | |
| Interaction | IRF1 interactions | 1.70e-07 | 83 | 60 | 6 | int:IRF1 | |
| Interaction | TLX3 interactions | 1.87e-07 | 291 | 60 | 9 | int:TLX3 | |
| Interaction | IRF4 interactions | 1.96e-07 | 85 | 60 | 6 | int:IRF4 | |
| Interaction | BCL9 interactions | 2.11e-07 | 86 | 60 | 6 | int:BCL9 | |
| Interaction | NUP35 interactions | 4.51e-07 | 424 | 60 | 10 | int:NUP35 | |
| Interaction | CEBPA interactions | ZNF680 PA2G4 TLE3 INPP5D SMARCA2 SMARCA4 ETV5 NCOA1 SMARCD1 PRPF6 FAM98B BCL9 NONO PRRC2A EP300 SCAF4 | 4.60e-07 | 1245 | 60 | 16 | int:CEBPA |
| Interaction | EYA4 interactions | 5.93e-07 | 243 | 60 | 8 | int:EYA4 | |
| Interaction | LDB2 interactions | 6.71e-07 | 56 | 60 | 5 | int:LDB2 | |
| Interaction | EGR2 interactions | 7.41e-07 | 171 | 60 | 7 | int:EGR2 | |
| Interaction | NR3C1 interactions | PHLDB1 PBRM1 PELP1 TLE3 SMARCA2 SMARCA4 NCOA1 SMARCD1 TSG101 BCL9 NONO EP300 AHNAK2 TBP | 7.48e-07 | 974 | 60 | 14 | int:NR3C1 |
| Interaction | SMARCA4 interactions | PBRM1 TLE3 TBX21 SMARCA2 SMARCA4 NCOA1 SMARCD1 SSBP3 NONO EP300 | 9.83e-07 | 462 | 60 | 10 | int:SMARCA4 |
| Interaction | LDB1 interactions | 1.18e-06 | 115 | 60 | 6 | int:LDB1 | |
| Interaction | PYGO1 interactions | 1.38e-06 | 28 | 60 | 4 | int:PYGO1 | |
| Interaction | NR1H4 interactions | 2.40e-06 | 32 | 60 | 4 | int:NR1H4 | |
| Interaction | AHR interactions | 2.64e-06 | 132 | 60 | 6 | int:AHR | |
| Interaction | NR4A1 interactions | 3.11e-06 | 212 | 60 | 7 | int:NR4A1 | |
| Interaction | WDR5 interactions | EIF2D PYGO2 PELP1 TLE3 SMARCA2 AUTS2 TSG101 PRPF6 FAM98B SNRPC NONO PRRC2A EP300 TBP | 3.18e-06 | 1101 | 60 | 14 | int:WDR5 |
| Interaction | FOS interactions | 3.84e-06 | 312 | 60 | 8 | int:FOS | |
| Interaction | KLF1 interactions | 4.36e-06 | 37 | 60 | 4 | int:KLF1 | |
| Interaction | NCOA1 interactions | 4.73e-06 | 146 | 60 | 6 | int:NCOA1 | |
| Interaction | ELF5 interactions | 4.92e-06 | 147 | 60 | 6 | int:ELF5 | |
| Interaction | RUNX1 interactions | 5.06e-06 | 324 | 60 | 8 | int:RUNX1 | |
| Interaction | GSC interactions | 6.05e-06 | 87 | 60 | 5 | int:GSC | |
| Interaction | SS18 interactions | 6.40e-06 | 88 | 60 | 5 | int:SS18 | |
| Interaction | ISL1 interactions | 6.62e-06 | 41 | 60 | 4 | int:ISL1 | |
| Interaction | ISL2 interactions | 6.62e-06 | 41 | 60 | 4 | int:ISL2 | |
| Interaction | SOX10 interactions | 7.96e-06 | 92 | 60 | 5 | int:SOX10 | |
| Interaction | FOXI1 interactions | 7.96e-06 | 92 | 60 | 5 | int:FOXI1 | |
| Interaction | SMARCA2 interactions | 8.19e-06 | 346 | 60 | 8 | int:SMARCA2 | |
| Interaction | RERE interactions | 8.39e-06 | 93 | 60 | 5 | int:RERE | |
| Interaction | DMRTB1 interactions | 8.84e-06 | 94 | 60 | 5 | int:DMRTB1 | |
| Interaction | IDI2 interactions | 8.92e-06 | 14 | 60 | 3 | int:IDI2 | |
| Interaction | DPF3 interactions | 9.31e-06 | 95 | 60 | 5 | int:DPF3 | |
| Interaction | DPF1 interactions | 9.31e-06 | 95 | 60 | 5 | int:DPF1 | |
| Interaction | CREBBP interactions | 9.87e-06 | 599 | 60 | 10 | int:CREBBP | |
| Interaction | CRX interactions | 1.02e-05 | 254 | 60 | 7 | int:CRX | |
| Interaction | GATA1 interactions | 1.17e-05 | 171 | 60 | 6 | int:GATA1 | |
| Interaction | PAX6 interactions | 1.23e-05 | 366 | 60 | 8 | int:PAX6 | |
| Interaction | SSBP2 interactions | 1.52e-05 | 105 | 60 | 5 | int:SSBP2 | |
| Interaction | CEBPB interactions | YTHDF1 PBRM1 PA2G4 TLE3 RBM42 SMARCA2 SMARCA4 TSG101 PRPF6 FAM98B SNRPC NONO PRRC2A EP300 SCAF4 | 1.53e-05 | 1443 | 60 | 15 | int:CEBPB |
| Interaction | HNF4A interactions | 1.70e-05 | 275 | 60 | 7 | int:HNF4A | |
| Interaction | HES6 interactions | 1.73e-05 | 52 | 60 | 4 | int:HES6 | |
| Interaction | ARID1A interactions | 1.74e-05 | 276 | 60 | 7 | int:ARID1A | |
| Interaction | NFIA interactions | 2.00e-05 | 188 | 60 | 6 | int:NFIA | |
| Interaction | HNF1B interactions | 2.13e-05 | 190 | 60 | 6 | int:HNF1B | |
| Interaction | QKI interactions | 2.13e-05 | 190 | 60 | 6 | int:QKI | |
| Interaction | SMARCE1 interactions | 2.24e-05 | 287 | 60 | 7 | int:SMARCE1 | |
| Interaction | SSBP3 interactions | 2.78e-05 | 119 | 60 | 5 | int:SSBP3 | |
| Interaction | DDIT3 interactions | 2.89e-05 | 120 | 60 | 5 | int:DDIT3 | |
| Interaction | WWP2 interactions | WBP2 PA2G4 SMARCA2 SMARCA4 FBXL15 SMARCD1 TSG101 PRPF6 SNRPC NONO PRRC2A | 3.26e-05 | 840 | 60 | 11 | int:WWP2 |
| Interaction | FLI1 interactions | 3.48e-05 | 62 | 60 | 4 | int:FLI1 | |
| Interaction | CDC5L interactions | ROCK2 EIF2D RBM42 SMARCA2 SMARCA4 SMARCD1 PRPF6 SSBP3 SNRPC NONO EP300 | 3.83e-05 | 855 | 60 | 11 | int:CDC5L |
| Interaction | BICRA interactions | 4.73e-05 | 67 | 60 | 4 | int:BICRA | |
| Interaction | TBX21 interactions | 4.86e-05 | 24 | 60 | 3 | int:TBX21 | |
| Interaction | ETV4 interactions | 5.31e-05 | 69 | 60 | 4 | int:ETV4 | |
| Interaction | PRP4K interactions | 5.33e-05 | 329 | 60 | 7 | int:PRP4K | |
| Interaction | TLE6 interactions | 5.51e-05 | 25 | 60 | 3 | int:TLE6 | |
| Interaction | SOX2 interactions | YTHDF1 USP34 COL11A1 PBRM1 PYGO2 PELP1 TLE3 SMARCA2 SMARCA4 SMARCD1 BCL9 SSBP3 EP300 ENOX2 | 5.68e-05 | 1422 | 60 | 14 | int:SOX2 |
| Interaction | SLF1 interactions | 6.21e-05 | 26 | 60 | 3 | int:SLF1 | |
| Interaction | SOX15 interactions | 6.26e-05 | 141 | 60 | 5 | int:SOX15 | |
| Interaction | SIRT7 interactions | USP34 COL5A1 PBRM1 PELP1 RNPEP SMARCA2 SMARCA4 PRPF6 HERC2 PRRC2A | 6.27e-05 | 744 | 60 | 10 | int:SIRT7 |
| Interaction | EGR1 interactions | 6.28e-05 | 72 | 60 | 4 | int:EGR1 | |
| Interaction | CPSF7 interactions | 6.32e-05 | 338 | 60 | 7 | int:CPSF7 | |
| Interaction | NFIB interactions | 6.47e-05 | 142 | 60 | 5 | int:NFIB | |
| Interaction | EWSR1 interactions | PELP1 SMARCA4 TSG101 SSBP2 PRPF6 BCL9 SSBP3 SNRPC NONO PRRC2A EP300 | 6.48e-05 | 906 | 60 | 11 | int:EWSR1 |
| Interaction | MAML1 interactions | 6.63e-05 | 73 | 60 | 4 | int:MAML1 | |
| Interaction | NR4A2 interactions | 6.97e-05 | 27 | 60 | 3 | int:NR4A2 | |
| Interaction | ZDHHC23 interactions | 6.99e-05 | 74 | 60 | 4 | int:ZDHHC23 | |
| Interaction | FUS interactions | PBRM1 PA2G4 SMARCA4 SMARCD1 PRPF6 SNRPC NONO PRRC2A EP300 SCAF4 | 7.25e-05 | 757 | 60 | 10 | int:FUS |
| GeneFamily | Collagens | 3.03e-08 | 46 | 36 | 5 | 490 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.14e-04 | 17 | 36 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.78e-04 | 18 | 36 | 2 | 91 | |
| GeneFamily | RNA binding motif containing | 8.21e-04 | 213 | 36 | 4 | 725 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.89e-03 | 206 | 36 | 3 | 682 | |
| Coexpression | NABA_COLLAGENS | 4.77e-08 | 43 | 60 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 5.38e-08 | 44 | 60 | 5 | M3005 | |
| Coexpression | TGFB_UP.V1_UP | 4.70e-06 | 189 | 60 | 6 | M2839 | |
| Coexpression | SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP | 1.71e-05 | 67 | 60 | 4 | M3695 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-07 | 193 | 60 | 6 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-07 | 193 | 60 | 6 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.55e-06 | 181 | 60 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.20e-06 | 186 | 60 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 5.47e-06 | 188 | 60 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 5.62e-06 | 189 | 60 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-06 | 189 | 60 | 5 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-06 | 194 | 60 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-06 | 197 | 60 | 5 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-06 | 197 | 60 | 5 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.59e-05 | 161 | 60 | 4 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.51e-05 | 177 | 60 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.51e-05 | 177 | 60 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-05 | 178 | 60 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.72e-05 | 178 | 60 | 4 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 180 | 60 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 180 | 60 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 180 | 60 | 4 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.04e-04 | 181 | 60 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 182 | 60 | 4 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.08e-04 | 183 | 60 | 4 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 183 | 60 | 4 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 183 | 60 | 4 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 183 | 60 | 4 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 185 | 60 | 4 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-04 | 185 | 60 | 4 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 186 | 60 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-04 | 187 | 60 | 4 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 188 | 60 | 4 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 190 | 60 | 4 | 933c778bb8ec89621906fe7d484c1d2c6cd28d80 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.25e-04 | 190 | 60 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 190 | 60 | 4 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 191 | 60 | 4 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 60 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 192 | 60 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 193 | 60 | 4 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 60 | 4 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.33e-04 | 193 | 60 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 193 | 60 | 4 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 60 | 4 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 194 | 60 | 4 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.35e-04 | 194 | 60 | 4 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.35e-04 | 194 | 60 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.38e-04 | 195 | 60 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | 15-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.38e-04 | 195 | 60 | 4 | 414f60bc0f0d0ecb5137bcd617fae91f0c15038a | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 196 | 60 | 4 | 59b5b5a0c123d0423abd19c312514849004b903b | |
| ToppCell | 15-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 1.41e-04 | 196 | 60 | 4 | b8d95b5f4780e73d16dcc528e70a5496f0314373 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 197 | 60 | 4 | b16add329bb35a558287ede51353010dde5bc029 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-04 | 197 | 60 | 4 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-04 | 197 | 60 | 4 | 6e111ba16fc8adde782b3f7da250248cddf11228 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.44e-04 | 197 | 60 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 1.44e-04 | 197 | 60 | 4 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-04 | 197 | 60 | 4 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.44e-04 | 197 | 60 | 4 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.44e-04 | 197 | 60 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-04 | 197 | 60 | 4 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 198 | 60 | 4 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 198 | 60 | 4 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 198 | 60 | 4 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-04 | 198 | 60 | 4 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 198 | 60 | 4 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-04 | 198 | 60 | 4 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 199 | 60 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.49e-04 | 199 | 60 | 4 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.49e-04 | 199 | 60 | 4 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.49e-04 | 199 | 60 | 4 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.49e-04 | 199 | 60 | 4 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 200 | 60 | 4 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 200 | 60 | 4 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 200 | 60 | 4 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 200 | 60 | 4 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 200 | 60 | 4 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-04 | 200 | 60 | 4 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Efhd2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.85e-04 | 82 | 60 | 3 | 93b75f8822ffe8870195cd1fe0a7286478f61e79 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.15e-04 | 136 | 60 | 3 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.15e-04 | 136 | 60 | 3 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-03 | 148 | 60 | 3 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-03 | 152 | 60 | 3 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 155 | 60 | 3 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 155 | 60 | 3 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-03 | 156 | 60 | 3 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.21e-03 | 156 | 60 | 3 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-03 | 156 | 60 | 3 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-03 | 159 | 60 | 3 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-03 | 159 | 60 | 3 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-03 | 159 | 60 | 3 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.28e-03 | 159 | 60 | 3 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-03 | 161 | 60 | 3 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-03 | 162 | 60 | 3 | bfaeff19bb56598fdc8c82be71d51787cf13928f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-03 | 163 | 60 | 3 | 6ed2a71385e85508ed513282c06440add7cc010c | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.40e-03 | 164 | 60 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-03 | 165 | 60 | 3 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-03 | 166 | 60 | 3 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | severe_influenza-CD4+_CTL|World / disease group, cell group and cell class (v2) | 1.45e-03 | 166 | 60 | 3 | cdc3e200373718f26fe02ee516928097103f46e2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-03 | 166 | 60 | 3 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.45e-03 | 166 | 60 | 3 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-03 | 167 | 60 | 3 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.47e-03 | 167 | 60 | 3 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-03 | 168 | 60 | 3 | 3fb79aaa858057c82645a90bd139fc4f096323c7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-03 | 168 | 60 | 3 | bfa1491e8d433933003778b274710d3a16d973cb | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 6.86e-07 | 194 | 59 | 7 | 7137_DN | |
| Drug | GK-101 | 2.25e-06 | 36 | 59 | 4 | CID000161853 | |
| Drug | Madecassol | 6.12e-06 | 46 | 59 | 4 | CID000108062 | |
| Drug | d-indobufen | 8.57e-06 | 50 | 59 | 4 | CID000044562 | |
| Drug | ridogrel | 1.00e-05 | 52 | 59 | 4 | CID005362391 | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.00e-05 | 191 | 59 | 6 | 7438_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.06e-05 | 193 | 59 | 6 | 1268_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 1.06e-05 | 193 | 59 | 6 | 1657_UP | |
| Drug | NSC49633 | 1.08e-05 | 53 | 59 | 4 | CID000023340 | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 1.13e-05 | 195 | 59 | 6 | 1665_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.13e-05 | 195 | 59 | 6 | 6098_DN | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 1.16e-05 | 196 | 59 | 6 | 5320_UP | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.16e-05 | 196 | 59 | 6 | 5288_UP | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 1.16e-05 | 196 | 59 | 6 | 7087_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.20e-05 | 197 | 59 | 6 | 4949_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.20e-05 | 197 | 59 | 6 | 1799_DN | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.20e-05 | 197 | 59 | 6 | 4818_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | 1.23e-05 | 198 | 59 | 6 | 6500_DN | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A | 1.23e-05 | 198 | 59 | 6 | 1287_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.27e-05 | 199 | 59 | 6 | 1705_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; PC3; HT_HG-U133A | 1.27e-05 | 199 | 59 | 6 | 7267_DN | |
| Drug | AC1L2E0P | 1.42e-05 | 307 | 59 | 7 | CID000019390 | |
| Drug | Selara | 1.82e-05 | 125 | 59 | 5 | CID000150310 | |
| Drug | AC1LAKND | 2.03e-05 | 62 | 59 | 4 | CID000470146 | |
| Drug | BAPN | 3.47e-05 | 71 | 59 | 4 | CID000001647 | |
| Drug | malotilate | 3.47e-05 | 71 | 59 | 4 | CID000004006 | |
| Drug | L-3,4-dehydroproline | 3.87e-05 | 73 | 59 | 4 | CID000094284 | |
| Drug | Dihydrotestosterone | 3.92e-05 | 360 | 59 | 7 | ctd:D013196 | |
| Drug | AC1NMZ1B | 4.31e-05 | 75 | 59 | 4 | CID005034185 | |
| Drug | strontium ranelate | 4.78e-05 | 77 | 59 | 4 | CID006918182 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 6.29e-05 | 162 | 59 | 5 | CID000072363 | |
| Drug | halofuginone lactate | 7.04e-05 | 85 | 59 | 4 | CID000062891 | |
| Drug | 4-hydroxyproline | 9.19e-05 | 91 | 59 | 4 | CID000000825 | |
| Drug | BPAT-143 | 9.84e-05 | 6 | 59 | 2 | CID000146249 | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.12e-04 | 183 | 59 | 5 | 7088_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.33e-04 | 190 | 59 | 5 | 836_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 1.37e-04 | 191 | 59 | 5 | 4647_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 1.40e-04 | 192 | 59 | 5 | 2101_DN | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 1.44e-04 | 193 | 59 | 5 | 974_DN | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 1.44e-04 | 193 | 59 | 5 | 7084_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.44e-04 | 193 | 59 | 5 | 864_DN | |
| Drug | Y-27632 | 1.46e-04 | 444 | 59 | 7 | CID000005711 | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.47e-04 | 194 | 59 | 5 | 7457_DN | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; HL60; HG-U133A | 1.47e-04 | 194 | 59 | 5 | 1783_UP | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.47e-04 | 194 | 59 | 5 | 1264_DN | |
| Drug | ticlopidine | 1.48e-04 | 103 | 59 | 4 | CID000005472 | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 2102_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 2121_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 7419_DN | |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 7257_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 7288_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 7277_DN | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 4389_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A | 1.54e-04 | 196 | 59 | 5 | 1982_UP | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 6994_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; HL60; HG-U133A | 1.54e-04 | 196 | 59 | 5 | 2023_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 4965_UP | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 4802_DN | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 1174_DN | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 5766_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 4485_DN | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; HL60; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 2401_UP | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 2868_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 4998_DN | |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 5285_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 5886_DN | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; HL60; HG-U133A | 1.62e-04 | 198 | 59 | 5 | 2013_DN | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; PC3; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 6289_UP | |
| Drug | rotenone; Down 200; 1uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 5943_DN | |
| Drug | Biotin [58-85-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 3289_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 5944_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 4592_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 6550_UP | |
| Drug | catechin; Down 200; 11uM; MCF7; HT_HG-U133A_EA | 1.62e-04 | 198 | 59 | 5 | 1101_DN | |
| Drug | Ronidazole [7681-76-7]; Down 200; 20uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 3557_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 2550_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 6321_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; HL60; HG-U133A | 1.66e-04 | 199 | 59 | 5 | 2016_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 7326_DN | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A | 1.66e-04 | 199 | 59 | 5 | 1739_UP | |
| Drug | 5230742; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 1.66e-04 | 199 | 59 | 5 | 862_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 2343_UP | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; HL60; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 1305_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.69e-04 | 200 | 59 | 5 | 4797_DN | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.69e-04 | 200 | 59 | 5 | 5774_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A | 1.69e-04 | 200 | 59 | 5 | 2175_DN | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.69e-04 | 200 | 59 | 5 | 6509_UP | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.69e-04 | 200 | 59 | 5 | 7315_DN | |
| Drug | hydroxylysine | 1.85e-04 | 109 | 59 | 4 | CID000001029 | |
| Drug | PD123177 | 1.89e-04 | 43 | 59 | 3 | CID000114899 | |
| Drug | AC1L1C2F | 1.91e-04 | 110 | 59 | 4 | CID000001711 | |
| Drug | NC-4 | 2.03e-04 | 44 | 59 | 3 | CID006420119 | |
| Drug | ribose-5-P | 2.05e-04 | 112 | 59 | 4 | CID000439167 | |
| Drug | PPACK | 2.12e-04 | 113 | 59 | 4 | CID003036757 | |
| Drug | AC1L9732 | 2.19e-04 | 114 | 59 | 4 | CID000439300 | |
| Drug | Tranilast sodium | 2.27e-04 | 115 | 59 | 4 | CID000005527 | |
| Drug | 8-bromoguanine | 3.53e-04 | 53 | 59 | 3 | CID000076473 | |
| Drug | estradiol 17-sulfate | 3.58e-04 | 11 | 59 | 2 | CID000066429 | |
| Drug | DMSe | 3.84e-04 | 132 | 59 | 4 | CID000020796 | |
| Drug | 1h00 | 4.16e-04 | 56 | 59 | 3 | CID000445950 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 4.22e-07 | 8 | 59 | 3 | C2677504 | |
| Disease | Prader-Willi syndrome | 9.02e-07 | 10 | 59 | 3 | cv:C0032897 | |
| Disease | PRADER-WILLI SYNDROME | 9.02e-07 | 10 | 59 | 3 | 176270 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.38e-06 | 41 | 59 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.38e-06 | 41 | 59 | 4 | C0858252 | |
| Disease | Royer Syndrome | 1.65e-06 | 12 | 59 | 3 | C0265222 | |
| Disease | Prader-Willi Syndrome | 2.14e-06 | 13 | 59 | 3 | C0032897 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.60e-06 | 195 | 59 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Stickler syndrome, type 1 | 3.92e-05 | 5 | 59 | 2 | C2020284 | |
| Disease | Stickler syndrome | 3.92e-05 | 5 | 59 | 2 | cv:C0265253 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.92e-05 | 5 | 59 | 2 | C3281201 | |
| Disease | Intervertebral disc disorder | 5.87e-05 | 6 | 59 | 2 | C0158252 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.40e-04 | 9 | 59 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.66e-04 | 53 | 59 | 3 | C4707243 | |
| Disease | prostate cancer (is_marker_for) | 2.73e-04 | 156 | 59 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Coffin-Siris syndrome | 3.02e-04 | 13 | 59 | 2 | C0265338 | |
| Disease | synophrys measurement | 3.47e-04 | 68 | 59 | 3 | EFO_0007906 | |
| Disease | psychosis | 3.52e-04 | 14 | 59 | 2 | EFO_0005407 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 3.52e-04 | 14 | 59 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | carotid atherosclerosis | 4.63e-04 | 16 | 59 | 2 | EFO_0009783 | |
| Disease | Breast Carcinoma | 7.10e-04 | 538 | 59 | 6 | C0678222 | |
| Disease | Multiple Epiphyseal Dysplasia | 7.30e-04 | 20 | 59 | 2 | C0026760 | |
| Disease | osteoarthritis, hip | 8.40e-04 | 92 | 59 | 3 | EFO_1000786 | |
| Disease | S-warfarin measurement | 9.80e-04 | 97 | 59 | 3 | EFO_0803323 | |
| Disease | Malignant neoplasm of breast | 1.28e-03 | 1074 | 59 | 8 | C0006142 | |
| Disease | eosinophil measurement | 1.34e-03 | 108 | 59 | 3 | EFO_0803540 | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 1.54e-03 | 29 | 59 | 2 | OBA_2045183 | |
| Disease | atopic eczema | 1.64e-03 | 252 | 59 | 4 | EFO_0000274 | |
| Disease | level of Sphingomyelin (d40:1) in blood serum | 1.88e-03 | 32 | 59 | 2 | OBA_2045182 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 1.94e-03 | 123 | 59 | 3 | EFO_0007789, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GMNPPPMTRGPSGHL | 1966 | Q09472 | |
| DLMLPGLVMPPAGLP | 111 | P41214 | |
| MPPSFPFGGMENPCL | 291 | Q9H4A4 | |
| MEMAAAPGRPGPPGK | 1466 | Q07092 | |
| MLPPMARAPGPPLGS | 206 | Q9BTD8 | |
| MGAPPSMLPEPGYNI | 366 | Q8IXN7 | |
| MPNGPMRITSGPFEP | 326 | Q9UQ80 | |
| GALMGVVPPPTPMGM | 1461 | Q86U86 | |
| SMGSMQPLHPGGPPP | 1506 | Q86U86 | |
| PAPPGPATMMPDGTL | 411 | Q15233 | |
| PATMMPDGTLGLTPP | 416 | Q15233 | |
| GGPMGKPPTPGVLMV | 96 | Q9UJ55 | |
| LGDMSPEGPQPPMIL | 2366 | O95714 | |
| AGPRPSMGMGVVPDP | 31 | Q9UJ90 | |
| PDFDPALGMMTGIPP | 61 | Q16206 | |
| TGIPPITPMMPGLGI | 71 | Q16206 | |
| GADGLPGPPGTMLML | 481 | P12107 | |
| PGPPGTMLMLPFRYG | 486 | P12107 | |
| GMPPPLVMSVSGPGC | 36 | Q9BZM3 | |
| MTPFMGISPLPGGER | 1046 | Q8WXX7 | |
| PGMPGPPAHGFQSPM | 276 | P41161 | |
| PPQLATMLLGMPGEG | 61 | Q96FB5 | |
| TPGPAAYMLPMVMGP | 136 | Q96PU9 | |
| GYMPMSPGVAPVPSG | 611 | P35568 | |
| HPPGPMPSVGSMPSA | 666 | Q8IZL8 | |
| SMPSAGPMPSAGPMP | 676 | Q8IZL8 | |
| GPMPSAGPMPSAGPV | 681 | Q8IZL8 | |
| SPPSGQMMPGPVGGF | 176 | Q9BRQ0 | |
| MARVPGPMGPNSGPS | 306 | P0CG12 | |
| QFPVMLEPMPPGEGA | 281 | P62683 | |
| EPGIMGPFGMPGTSI | 576 | Q2UY09 | |
| LGLPPGMAMEGIRPS | 641 | O00512 | |
| NIPPHGVPMGPGLMS | 1101 | O00512 | |
| PRGSMGPMGPSPDLS | 281 | Q6UXH8 | |
| REALGAVGMMGPPGP | 546 | Q14055 | |
| GLPGPPGTMLMLPFR | 511 | P20908 | |
| MRGPEPGPQPTMEGD | 1 | Q52LJ0 | |
| MQPGSAPPPGRMDPS | 1 | Q5T890 | |
| SSSSMPGLGMVPPPP | 866 | Q9NZ56 | |
| GFAMPPPHGMKGPFP | 896 | O95104 | |
| SLPPMPLGPGMDLLG | 596 | Q8N2Y8 | |
| MRPPLNALGGPGMPG | 196 | P81877 | |
| RPNFPMGPGSDGPMG | 281 | P81877 | |
| SGMRPPPNSLGPAMP | 221 | Q9BWW4 | |
| MSTPTDPGAMPHPGP | 1 | P51531 | |
| SPMPGAAYPRPGMLP | 51 | Q96GM5 | |
| PGMLPGSRMTPQGPS | 61 | Q96GM5 | |
| GSRMTPQGPSMGPPG | 66 | Q96GM5 | |
| VGPAPGMRPPMGGHM | 116 | P09234 | |
| AGIPMGPMPAAGMPY | 81 | Q9UMZ2 | |
| GPMPAAGMPYLGQAP | 86 | Q9UMZ2 | |
| PLSPSPPMGAPLGMH | 386 | Q15270 | |
| PYPGGMTPGLMTPGT | 221 | O94906 | |
| TPPRGAFSPGMGMQP | 1026 | Q15788 | |
| MEPPMEPSGGEQEPG | 1 | Q9H469 | |
| GALGRPPPMPPMNFD | 706 | P48634 | |
| PGSAHSMMGPSPGPP | 36 | P51532 | |
| SMMGPSPGPPSAGHP | 41 | P51532 | |
| MGVGPFGPPMPLHVK | 916 | Q92835 | |
| TIPGPQVIMGPGTPM | 1001 | Q9NZP6 | |
| PSKGPLPFQMPGMRL | 5301 | Q8IVF2 | |
| TGPPNTSYMPGMPGG | 156 | Q99816 | |
| PIFSPMMPYGTGLTP | 26 | P20226 | |
| PLGPGPEGPMAAMSA | 306 | Q9BWG4 | |
| MSRPPPTGKMPGAPE | 1 | O75116 | |
| MKSMIPAGGRAPGPP | 141 | Q86UU1 | |
| GLRSMPGKPPGMDPI | 336 | Q04726 | |
| PGKPPGMDPIGIMAS | 341 | Q04726 | |
| MEFAGGPPGMPPFAS | 2611 | Q70CQ2 | |
| MPGPPGSLEMGPLTF | 1 | Q8NEM1 | |
| MRTLPMEPGPGGSEG | 451 | Q9UL17 | |
| MGGGLPPPPIKHNMD | 256 | Q9BYJ9 | |
| MPGAPGSLEMGPLTF | 1 | A6NN14 | |
| VGRPRMMGTGLPPYP | 216 | Q6ZMS7 | |
| PGPPMMDGAMGYVQP | 181 | Q969T9 |